Ferenc Tracik

494 total citations
25 papers, 344 citations indexed

About

Ferenc Tracik is a scholar working on Pharmacology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Ferenc Tracik has authored 25 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Cognitive Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Ferenc Tracik's work include Cholinesterase and Neurodegenerative Diseases (8 papers), Sleep and Wakefulness Research (6 papers) and Sleep and related disorders (4 papers). Ferenc Tracik is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (8 papers), Sleep and Wakefulness Research (6 papers) and Sleep and related disorders (4 papers). Ferenc Tracik collaborates with scholars based in Germany, Switzerland and United States. Ferenc Tracik's co-authors include Georg Ebersbach, Peter Geisler, Adam Wichniak, Matthias W. Riepe, Georg Adler, Jürgen Zulley, İbrahim Günay, Bernd Ibach, Tatjana Crönlein and Monika Baier and has published in prestigious journals such as Neurology, SLEEP and Psychopharmacology.

In The Last Decade

Ferenc Tracik

24 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferenc Tracik Germany 12 118 115 90 69 65 25 344
Giordano D’Andreamatteo Italy 9 231 2.0× 183 1.6× 68 0.8× 107 1.6× 30 0.5× 15 495
Jamila Ahdidan Denmark 9 139 1.2× 50 0.4× 134 1.5× 30 0.4× 41 0.6× 10 433
Alessandro Alvano Italy 9 29 0.2× 120 1.0× 100 1.1× 40 0.6× 50 0.8× 11 333
Andrew J. Holman United States 9 142 1.2× 89 0.8× 310 3.4× 32 0.5× 225 3.5× 17 515
Stephen Thein United States 10 216 1.8× 88 0.8× 43 0.5× 108 1.6× 13 0.2× 15 356
Rocco de Filippis Italy 9 36 0.3× 77 0.7× 142 1.6× 31 0.4× 117 1.8× 30 327
Nataša Klepac Croatia 13 82 0.7× 211 1.8× 129 1.4× 40 0.6× 40 0.6× 28 487
M. Barbanoj Spain 11 224 1.9× 70 0.6× 32 0.4× 25 0.4× 42 0.6× 24 451
Petros Malitas Greece 10 30 0.3× 29 0.3× 130 1.4× 49 0.7× 36 0.6× 17 349

Countries citing papers authored by Ferenc Tracik

Since Specialization
Citations

This map shows the geographic impact of Ferenc Tracik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferenc Tracik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferenc Tracik more than expected).

Fields of papers citing papers by Ferenc Tracik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferenc Tracik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferenc Tracik. The network helps show where Ferenc Tracik may publish in the future.

Co-authorship network of co-authors of Ferenc Tracik

This figure shows the co-authorship network connecting the top 25 collaborators of Ferenc Tracik. A scholar is included among the top collaborators of Ferenc Tracik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferenc Tracik. Ferenc Tracik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Haas, Jürgen, et al.. (2012). Fingolimod-Compassionate-use-Programm. Der Nervenarzt. 83(12). 1575–1581. 1 indexed citations
5.
Mäurer, M., et al.. (2012). Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients. Multiple Sclerosis Journal. 19(5). 631–638. 21 indexed citations
6.
Baier, Monika, et al.. (2011). A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer’s disease. International Journal of Clinical Practice. 65(7). 790–796. 18 indexed citations
7.
Fleischhaker, Christian, Klaus Hennighausen, Philip Heiser, et al.. (2010). A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin ® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting. Journal of Child and Adolescent Psychopharmacology. 20(5). 377–385. 20 indexed citations
8.
Kaußner, Yvonne, Ramona Kenntner‐Mabiala, Sonja Hoffmann, et al.. (2010). Effects of oxcarbazepine and carbamazepine on driving ability: a double-blind, randomized crossover trial with healthy volunteers. Psychopharmacology. 210(1). 53–63. 24 indexed citations
9.
Haessler, Frank, Ferenc Tracik, Hartmut Dietrich, Holger Stammer, & Jan Klatt. (2008). A pharmacokinetic study of two modified-release methylphenidate formulations under different food conditions in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 46(9). 466–476. 16 indexed citations
10.
Riepe, Matthias W., et al.. (2007). Domain-Specific Improvement of Cognition on Memantine in Patients with Alzheimer’s Disease Treated with Rivastigmine. Dementia and Geriatric Cognitive Disorders. 23(5). 301–306. 24 indexed citations
11.
Geisler, Peter, Ferenc Tracik, Tatjana Crönlein, et al.. (2006). The Influence of Age and Sex on Sleep Latency in the MSLT-30—A Normative Study. SLEEP. 29(5). 687–692. 26 indexed citations
12.
Mahlberg, Richard, et al.. (2006). Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: A placebo-controlled pilot study. Archives of Gerontology and Geriatrics. 45(1). 19–26. 21 indexed citations
13.
Keller, Ingo, B Husemann, Klaus Scheidtmann, & Ferenc Tracik. (2006). Verlauf kognitiver Störungen nach Schädel-Hirn-Trauma unter Rivastigmin. Zeitschrift für Neuropsychologie. 17(4). 257–267. 1 indexed citations
14.
Riepe, Matthias W., et al.. (2006). Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease. The Primary Care Companion For CNS Disorders. 8(5). 258–63. 25 indexed citations
15.
Riepe, Matthias W., Jan Kassubek, Ferenc Tracik, & Georg Ebersbach. (2006). Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?. Journal of Neural Transmission. 113(10). 1463–1468. 4 indexed citations
16.
Wichniak, Adam, Peter Geisler, Hans Brünner, et al.. (2003). Spectral composition of NREM sleep in healthy subjects with moderately increased daytime sleepiness. Clinical Neurophysiology. 114(8). 1549–1555. 11 indexed citations
17.
Wichniak, Adam, Peter Geisler, Ferenc Tracik, et al.. (2002). The influence of polysomnography on the Multiple Sleep Latency Test and other measures of daytime sleepiness. Physiology & Behavior. 75(1-2). 183–188. 5 indexed citations
18.
Wichniak, Adam, Ferenc Tracik, Peter Geisler, et al.. (2001). Rhythmic feet movements while falling asleep. Movement Disorders. 16(6). 1164–1170. 27 indexed citations
19.
Tracik, Ferenc & Georg Ebersbach. (2001). Sudden daytime sleep onset in Parkinson's disease: Polysomnographic recordings. Movement Disorders. 16(3). 500–506. 62 indexed citations
20.
Ebersbach, Georg, Ferenc Tracik, Jörg Wissel, & Werner Poewe. (1997). Tardive jaw tremor. Movement Disorders. 12(3). 460–462. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026